
In an important first step towards achieving increased funding for the Food and Drug Administration (FDA), members of a Senate appropriations subcommittee approved an additional $275 million in appropriations for the agency. The additional resources would provide a significant boost to the FDA's ability to monitor drug safety.
Click here for full Story http://www.medicalnewstoday.com/articles/106787.php |